Specifically, early-onset AD (which manifests in individuals under 65 years of age) is associated with mutations in the APP (amyloid precursor protein), PSEN1 (presenilin 1) and PSEN2 (presenilin 2) genes. This evidence concerns the gene PSEN2 and Alzheimer disease.